Afrikaans
Albanian
Amharic
Arabic
Armenian
Azerbaijani
Basque
Belarusian
Bengali
Bosnian
Bulgarian
Catalan
Cebuano
Chichewa
Chinese (Simplified)
Chinese (Traditional)
Corsican
Croatian
Czech
Danish
Dutch
English
Esperanto
Estonian
Filipino
Finnish
French
Frisian
Galician
Georgian
German
Greek
Gujarati
Haitian Creole
Hausa
Hawaiian
Hebrew
Hindi
Hmong
Hungarian
Icelandic
Igbo
Indonesian
Irish
Italian
Japanese
Javanese
Kannada
Kazakh
Khmer
Korean
Kurdish (Kurmanji)
Kyrgyz
Lao
Latin
Latvian
Lithuanian
Luxembourgish
Macedonian
Malagasy
Malay
Malayalam
Maltese
Maori
Marathi
Mongolian
Myanmar (Burmese)
Nepali
Norwegian
Pashto
Persian
Polish
Portuguese
Punjabi
Romanian
Russian
Samoan
Scottish Gaelic
Serbian
Sesotho
Shona
Sindhi
Sinhala
Slovak
Slovenian
Somali
Spanish
Sudanese
Swahili
Swedish
Tajik
Tamil
Telugu
Thai
Turkish
Ukrainian
Urdu
Uzbek
Vietnamese
Welsh
Xhosa
Yiddish
Yoruba
ZuluIron Sucrose Injection
Iron Sucrose Injection
Ask for Catalogue
Advin Dialysis Iron Sucrose Injection is used for the treatment of iron deficiency anemia in chronic kidney disease (CKD) patients, including those on hemodialysis.
- International Quality Standard.
- Fastest Delivery.
- Export Standard Packaging.
- Customized Production.
Iron Sucrose Injection from Advin Dialysis is a parenteral iron therapy formulated for the effective treatment of iron deficiency anemia in patients with chronic kidney disease, particularly those undergoing regular hemodialysis. It works by replenishing iron stores necessary for red blood cell production, especially in patients concurrently treated with erythropoiesis-stimulating agents (ESAs) like EPO.
Advin Iron Sucrose is manufactured under stringent quality standards and ensures high bioavailability with minimal side effects. It provides rapid correction of iron levels, helping to restore hemoglobin and improve the overall quality of life in dialysis patients.
Advanced Features
- High-purity iron sucrose complex for rapid absorption
- Suitable for patients with CKD on or off dialysis
- Can be administered intravenously during dialysis sessions
- Reduces the need for oral iron supplements
- Compatible with erythropoietin (EPO) therapy
- Minimal risk of anaphylaxis compared to older iron preparations
- Available in various strengths (e.g., 100 mg/5 ml vial)
- Sterile, non-pyrogenic formulation
Urology Division
Laparoscopy Division
Gynecology Division
Nephrology Division
Cardiology Division
